Browse by author
Lookup NU author(s): Dr Ian HardcastleORCiD
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
A series of homologs of idoxifene [1a, (E)-1-[4-(N-pyrrolidinoethoxy)phenyl]-1-(4-iodophenyl)-2-phenyl-1-butene] and selected homologs of 4-iodotamoxifen [2a, (E)-1-[4-[(N-dimethylamino)ethoxy]phenyl]-1-(4-iodophenyl)-2-phenyl-1-butene] with the side chain (CH2)n varying in length from n = 3 (1b, 2b) to n = 10 (1i, 2i) have been synthesized and tested for antagonism of the calmodulin-dependent activity of cAMP phosphodiesterase and for binding affinity to rat uterine estrogen receptor. Compared with 1a (IC50 = 1.5 μM), the homologs showed a progressive increase in calmodulin antagonism with a maximum inhibition at n = 7−9 (1f−h) (IC50 = 0.2 μM), declining at n = 10 (1i) to IC50 = 1.6 μM. In the pyrrolidino series, estrogen receptor binding affinity peaked at n = 3 (1b, RBA = 23; estradiol = 100), declining by n = 10 (1i) to RBA = 0.4, but the homolog n = 8 (1g, RBA = 3.5) was still comparable to tamoxifen (RBA = 3.9). A similar pattern of activity was seen for the dimethylamino counterparts. These compounds represent a new class of antiestrogens with potent calmodulin antagonism.
Author(s): Hardcastle IR, Rowlands MG, Grimshaw RM, Houghton J, Jarman M
Publication type: Article
Publication status: Published
Journal: Journal of Medicinal Chemistry
Year: 1996
Volume: 39
Issue: 4
Pages: 999-1004
Print publication date: 16/10/1996
ISSN (print): 0022-2623
ISSN (electronic): 1520-4804
Publisher: American Chemical Society
URL: http://dx.doi.org/10.1021/jm9505472
DOI: 10.1021/jm9505472
Altmetrics provided by Altmetric